Valuation: Mega Lifesciences

Market Cap 3.27TCr 98Cr 86Cr 80Cr 73Cr 137.6Cr 9.33TCr 139.96Cr 946.78Cr 370.58Cr 4.63TCr 366.61Cr 358.69Cr 16TCr P/E 2026 *
14x
P/E 2027 * 13.2x
Enterprise Value 2.81TCr 84Cr 74Cr 69Cr 63Cr 118.19Cr 8.01TCr 120.22Cr 813.24Cr 318.31Cr 3.97TCr 314.9Cr 308.1Cr 14TCr EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.78x
Free-Float
38.61%
Yield 2026 *
4.7%
Yield 2027 * 5.03%
1 day+0.67%
1 week-0.66%
Current month+2.04%
1 month+7.14%
3 months+7.14%
6 months+4.17%
Current year+11.94%
1 week 37
Extreme 37
38.5
1 month 35.5
Extreme 35.5
38.5
Current year 31.5
Extreme 31.5
40
1 year 27.75
Extreme 27.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 16.2
Extreme 16.2
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%-0.66% - - 98Cr
+1.93%+3.85%+51.05%+166.24% 1,08900Cr
+0.29%+6.43%+60.47%+52.87% 64TCr
+2.45%+2.77%+39.61%+74.48% 47TCr
-0.26%+10.32%+41.31%+35.51% 36TCr
-0.08%+4.04%+37.67%+43.19% 30TCr
+0.71%+2.74%+16.96%+16.66% 27TCr
-0.25%+4.55%-3.70%-38.83% 23TCr
+4.48%+7.33%+30.47%+66.31% 21TCr
+2.91%+3.10%+18.84%+74.76% 17TCr
Average +1.37%+5.07%+32.52%+54.58% 41.46TCr
Weighted average by Cap. +1.45%+5.14%+40.85%+79.77%

Financials

2026 *2027 *
Net sales 1.49TCr 45Cr 39Cr 36Cr 33Cr 63Cr 4.26TCr 64Cr 431.91Cr 169.05Cr 2.11TCr 167.24Cr 163.63Cr 7.29TCr 1.57TCr 47Cr 41Cr 38Cr 35Cr 66Cr 4.48TCr 67Cr 454.32Cr 177.83Cr 2.22TCr 175.92Cr 172.12Cr 7.67TCr
Net income 233.16Cr 6.96Cr 6.11Cr 5.69Cr 5.23Cr 9.81Cr 665.31Cr 9.98Cr 68Cr 26Cr 329.95Cr 26Cr 26Cr 1.14TCr 247.23Cr 7.38Cr 6.48Cr 6.03Cr 5.55Cr 10Cr 705.47Cr 11Cr 72Cr 28Cr 349.87Cr 28Cr 27Cr 1.21TCr
Net Debt -461.15Cr -14Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -20Cr -133.54Cr -52Cr -652.58Cr -52Cr -51Cr -2.25TCr -475.96Cr -14Cr -12Cr -12Cr -11Cr -20Cr -1.36TCr -20Cr -137.83Cr -54Cr -673.54Cr -53Cr -52Cr -2.33TCr
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
27/26/27 THB 37.50 +0.67% 8,50,000
24/26/24 THB 37.25 -0.67% 5,06,400
23/26/23 THB 37.50 -1.96% 5,64,600
22/26/22 THB 38.25 +1.32% 12,98,800
21/26/21 THB 37.75 0.00% 5,39,100
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
37.50THB
Average target price
41.71THB
Spread / Average Target
+11.24%

Quarterly revenue - Rate of surprise